---
title: "石藥集團創新藥 SYH2085 獲准開展臨牀試驗"
description: "石藥集團公佈，集團開發的化學 1 類創新藥 SYH2085 片獲中國國家藥品監督管理局批准，可在中國開展臨牀試驗。本次獲批的臨牀適應症為用於治療成人及 12 歲以上青少年單純性甲型和乙型流感。"
type: "news"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/270403949.md"
published_at: "2025-12-21T12:01:54.000Z"
---

# 石藥集團創新藥 SYH2085 獲准開展臨牀試驗

> 石藥集團公佈，集團開發的化學 1 類創新藥 SYH2085 片獲中國國家藥品監督管理局批准，可在中國開展臨牀試驗。本次獲批的臨牀適應症為用於治療成人及 12 歲以上青少年單純性甲型和乙型流感。

石藥集團 (01093.HK) 公佈，集團開發的化學 1 類創新藥 SYH2085 片獲中國國家藥品監督管理局批准，可在中國開展臨牀試驗。本次獲批的臨牀適應症為用於治療成人及 12 歲以上青少年單純性甲型和乙型流感。

### Related Stocks

- [01093.HK - 石藥集團](https://longbridge.com/zh-HK/quote/01093.HK.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| CSPC Pharma Gets China Nod for Multiple Drug Trials | CSPC Pharma Gets China Nod for Multiple Drug Trials | [Link](https://longbridge.com/zh-HK/news/270994613.md) |
| CICC Sticks to Its Buy Rating for CSPC Pharmaceutical Group (CHJTF) | CICC has reaffirmed its Buy rating for CSPC Pharmaceutical Group (CHJTF) with a price target of HK$12.00. Additionally,  | [Link](https://longbridge.com/zh-HK/news/274393834.md) |
| 11:08 ETAmericans Wash Hands More During Flu Season but Everyday Habits Still Fall Short, New Survey Finds | A recent survey reveals that 70% of Americans are concerned about contracting the flu, up from 59% three years ago. The  | [Link](https://longbridge.com/zh-HK/news/275633689.md) |
| CSPC Pharma Unit Files Application with HKEX for Proposed H-Share Listing | CSPC Pharma Unit Files Application with HKEX for Proposed H-Share Listing | [Link](https://longbridge.com/zh-HK/news/269327436.md) |
| Kolter Homes Celebrates Grand Opening of New Design Studio at Esprit at Avenir | Kolter Homes has announced the grand opening of a new Design Studio at Esprit at Avenir, a luxury 55+ community in Palm  | [Link](https://longbridge.com/zh-HK/news/275792538.md) |

---

> **免責聲明**：本文內容僅供參考，不構成任何投資建議。